Notch4 Negatively Regulates the Inflammatory Response to Mycobacterium Tuberculosis Infection by Inhibiting TAK1 Activation

Ruijuan Zheng,Haipeng Liu,Yilong Zhou,Dapeng Yan,Jianxia Chen,Dapeng Ma,Yonghong Feng,Lianhua Qin,Feng Liu,Xiaochen Huang,Jie Wang,Baoxue Ge
DOI: https://doi.org/10.1093/infdis/jix636
2017-01-01
The Journal of Infectious Diseases
Abstract:Tuberculosis, caused by Mycobacterium tuberculosis infection, remains a global threat to human health, but knowledge of the molecular mechanisms underlying the pathogenesis of tuberculosis is still limited. Although Notch4, a member of the Notch receptor family, is involved in the initiation of mammary tumors, its function in M. tuberculosis infection remains unclear. In this study, we found that Notch4-deficient mice were more resistant to M. tuberculosis infection, with a much lower bacterial burden and fewer pathological changes in the lungs. Notch4 inhibited M. tuberculosis-induced production of proinflammatory cytokines by interaction with TAK1 and inhibition of its activation. Furthermore, we found that Notch intracellular domain 4 prevented TRAF6 autoubiquitination and suppressed TRAF6-mediated TAK1 polyubiquitination. Finally, Notch inhibitors made mice more resistant to M. tuberculosis infection. These results suggest that Notch4 is a negative regulator of M. tuberculosis-induced inflammatory response, and treatment with a Notch inhibitor could serve as a new therapeutic strategy for tuberculosis.
What problem does this paper attempt to address?